These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 24167220

  • 1. Selective inhibition of cytochrome P450 2D6 by Sarpogrelate and its active metabolite, M-1, in human liver microsomes.
    Cho DY, Bae SH, Lee JK, Kim YW, Kim BT, Bae SK.
    Drug Metab Dispos; 2014 Jan; 42(1):33-9. PubMed ID: 24167220
    [Abstract] [Full Text] [Related]

  • 2. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    Bae SH, Kwon MJ, Choi EJ, Zheng YF, Yoon KD, Liu KH, Bae SK.
    Chem Biol Interact; 2013 Sep 05; 205(1):11-9. PubMed ID: 23777987
    [Abstract] [Full Text] [Related]

  • 3. Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6.
    Song M, Hong M, Lee MY, Jee JG, Lee YM, Bae JS, Jeong TC, Lee S.
    Food Chem Toxicol; 2013 Sep 05; 59():549-53. PubMed ID: 23835282
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes.
    Kim KA, Park JY.
    Drug Metab Dispos; 2003 Sep 05; 31(9):1090-2. PubMed ID: 12920163
    [Abstract] [Full Text] [Related]

  • 7. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
    Wójcikowski J, Danek PJ, Basińska-Ziobroń A, Pukło R, Daniel WA.
    Pharmacol Rep; 2020 Jun 05; 72(3):612-621. PubMed ID: 32219694
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Desvenlafaxine and venlafaxine exert minimal in vitro inhibition of human cytochrome P450 and P-glycoprotein activities.
    Oganesian A, Shilling AD, Young-Sciame R, Tran J, Watanyar A, Azam F, Kao J, Leung L.
    Psychopharmacol Bull; 2009 Jun 05; 42(2):47-63. PubMed ID: 19629022
    [Abstract] [Full Text] [Related]

  • 10. The potential for CYP2D6 inhibition screening using a novel scintillation proximity assay-based approach.
    Delaporte E, Slaughter DE, Egan MA, Gatto GJ, Santos A, Shelley J, Price E, Howells L, Dean DC, Rodrigues AD.
    J Biomol Screen; 2001 Aug 05; 6(4):225-31. PubMed ID: 11689122
    [Abstract] [Full Text] [Related]

  • 11. Metabolism of dextromethorphan in vitro: involvement of cytochromes P450 2D6 and 3A3/4, with a possible role of 2E1.
    Schmider J, Greenblatt DJ, Fogelman SM, von Moltke LL, Shader RI.
    Biopharm Drug Dispos; 1997 Apr 05; 18(3):227-40. PubMed ID: 9113345
    [Abstract] [Full Text] [Related]

  • 12. Interaction of terfenadine and its primary metabolites with cytochrome P450 2D6.
    Jones BC, Hyland R, Ackland M, Tyman CA, Smith DA.
    Drug Metab Dispos; 1998 Sep 05; 26(9):875-82. PubMed ID: 9733666
    [Abstract] [Full Text] [Related]

  • 13. Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes.
    Guo Z, Raeissi S, White RB, Stevens JC.
    Drug Metab Dispos; 1997 Mar 05; 25(3):390-3. PubMed ID: 9172960
    [Abstract] [Full Text] [Related]

  • 14. Timolol metabolism in human liver microsomes is mediated principally by CYP2D6.
    Volotinen M, Turpeinen M, Tolonen A, Uusitalo J, Mäenpää J, Pelkonen O.
    Drug Metab Dispos; 2007 Jul 05; 35(7):1135-41. PubMed ID: 17431033
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.
    Micuda S, Mundlova L, Anzenbacherova E, Anzenbacher P, Chladek J, Fuksa L, Martinkova J.
    Eur J Clin Pharmacol; 2004 Oct 05; 60(8):583-9. PubMed ID: 15378224
    [Abstract] [Full Text] [Related]

  • 16. The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6.
    Mankowski DC.
    Drug Metab Dispos; 1999 Sep 05; 27(9):1024-8. PubMed ID: 10460802
    [Abstract] [Full Text] [Related]

  • 17. Application of physiologically based pharmacokinetic modeling in predicting drug-drug interactions for sarpogrelate hydrochloride in humans.
    Min JS, Kim D, Park JB, Heo H, Bae SH, Seo JH, Oh E, Bae SK.
    Drug Des Devel Ther; 2016 Sep 05; 10():2959-2972. PubMed ID: 27695293
    [Abstract] [Full Text] [Related]

  • 18. The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6.
    Madeira M, Levine M, Chang TK, Mirfazaelian A, Bellward GD.
    Drug Metab Dispos; 2004 Apr 05; 32(4):460-7. PubMed ID: 16680870
    [Abstract] [Full Text] [Related]

  • 19. Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms.
    Or PM, Lam FF, Kwan YW, Cho CH, Lau CP, Yu H, Lin G, Lau CB, Fung KP, Leung PC, Yeung JH.
    Phytomedicine; 2012 Apr 15; 19(6):535-44. PubMed ID: 22261394
    [Abstract] [Full Text] [Related]

  • 20. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T, Shiraga T, Mitani Y, Terakawa M, Tokuma Y, Kagayama A.
    Drug Metab Dispos; 2000 Sep 15; 28(9):1128-34. PubMed ID: 10950860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.